Characterization of Immune Cells in Inflammatory and Degenerative Diseases of the Human Eye

Characterization of Immune Cells in Inflammatory and Degenerative Diseases of the Human Eye - Immune Cells in the Eye

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023886

Enrollment

500

Registered

2020-12-18

Start date

2020-12-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory and Degenerative Diseases of the Human Eye

Interventions

Group 1: Patients with inflammatory or neurodegenerative disease of the eye

eye tissue and blood samples are used, which would be taken anyway as part of the intended diagnostic or therapeutic measures and would otherwise be destroyed. Group 2: Control patients undergoing ret

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with inflammatory or neurodegenerative disease of the eye and control patients undergoing retinal surgery for other indications

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The aim of the study is to analyze the histological, immunohistochemical, flow cytometric and molecular genetic profile of immune cells in the human eye in patients with inflammatory and neurodegenerative diseases.	—

Countries

Germany

Contacts

Public ContactStefaniya Boneva

Klinik für Augenheilkunde, Universitätsklinikum Freiburg

stefaniya.boneva@uniklinik-freiburg.de0761 27040512

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026